Similarweb Ltd. Ordinary Shares (SMWB)
Live price chart, market sentiment, and community perspectives for Similarweb Ltd. (NYSE: SMWB).
Live price chart, market sentiment, and community perspectives for Similarweb Ltd. (NYSE: SMWB).
Options skew in SMWB is leaning heavily bearish into the next rate cycle decision. Watching the 50-day moving average closely for an inflection.
Order flow on SMWB suggests systematic accumulation by long-only institutional accounts during yesterday's dip.
Valuation on Similarweb Ltd. Ordinary Shares (SMWB) is stretched relative to sovereign debt yields, but short interest is too crowded to bet on immediate downside.
Option volume on SMWB indicates large block hedging by prime desks. Downside asymmetry is expanding.
On our desk, SMWB's trajectory throughout late 2025 and into mid-2026 reads like a textbook turnaround into a high-margin compounding machine. Seeing multi-year subscriptions climb from 49% up to 64% of ARR provides immense forward revenue visibility. When you combine that structural stickiness with their first-ever quarter of positive GAAP operating profit in Q2 2026 and an NRR recovery back to 100%, the market sentiment shift from speculative growth to profitable AI play is entirely justified. Market participants should watch how effectively they integrate these massive eight-figure ARR big tech expansions into sustained organic growth.
From a quantitative risk perspective, Similarweb's operational execution has markedly de-risked the equity profile over the past year. Delivering revenue and non-GAAP operating profit consistently at the top end or above guidance ranges—alongside ten consecutive quarters of positive normalized free cash flow—demonstrates disciplined cost management alongside top-line durability. However, valuations will increasingly depend on whether the acceleration in AI data contracts can offset broader enterprise software spending fluctuations. The raised lower end of the 2026 guidance shows management's internal visibility is currently high.
Explore plasma cleansing, somatic organ swaps, and BCI.